JSS Medical Research, a Montreal, Canada-based CRO, has acquired Max Neeman International (MNI), a full-service CRO based in New Delhi, India. Additional regional offices are located in Ahmedabad, Bangalore, Chennai and Mumbai. Through a U.S. subsidiary, a regional office also is located in North Carolina.
This global expansion in India follows the acquisition of Latam Clinical Trials, a CRO in Bogota, Colombia, that established the company's presence in Latin America.
"Our collaborations with MNI in recent years have enabled us to have first-hand evidence of the quality, integrity, credibility and client centric focus of this organization that is comparable to our philosophy," said Stella Boukas, chief operating officer of JSS Medical Research.
"This expansion enables us to provide our large pharmaceutical clients with our services to their regional affiliates in India and surrounding regions. For our biotech clients, the expansion will provide them with access to patients and high quality research sites that will facilitate the completion of their clinical development programs. This is an important step for JSS Medical Research in its evolution as a niche global CRO and a major achievement for the Canadian and Quebec Health Care Research Industry, because it is testimony to the fact that the quality and value of the scientific work done here transcends geographic borders and limits,” said Dr. John S. Sampalis, CEO of JSS Medical Research.
Dr. Toni Rinow, chief financial officer at JSS Medical Research, added that JSS continues on its global expansion strategy and is seeking to further strengthen its position in the US and in Europe supported by its financial partners.